Fatty Liver Disease – Houma

Liver icon
Age 18 to 75
Sex Male or Female
Conditons Fatty Liver Disease (NASH)
Locations Houma

Are You at Risk for Non-Alcoholic, Fatty Liver Disease?

Currently, no drugs are globally approved for the treatment of Non-Alcoholic Steatohepatitis (NASH). First-line treatment is lifestyle intervention to achieve weight loss and treatment of other co-existing conditions like high blood pressure and diabetes. But other effective treatments for patients with NASH are needed.  

That’s why ClinCloud is looking for volunteers with NASH for a research study of an investigational medication. To qualify, you must:

  • Be 18 to 75 years of age
  • Have a diagnosis of NASH 

Early signs may include the following:

  • Weight Loss
  • Fatigue
  • Weakness
  • Web-like clusters of blood vessels under your skin
  • Nosebleeds
  • Itchy Skin
  • Yellow skin and eyes
  • Loss of appetite

Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below!

Diseased liver

Liver Disease Research Study Form

Qualify for a Study
Check off the studies of interest
consent
consent2